Collaboration commercializing technology for reusing complex catalysts
| By Scott Jenkins
The manufacture of pharmaceuticals and many fine chemicals requires costly, toxic catalysts with metal atoms bonded to complex organic ligands that catalyze the creation of chiral centers. Current processes often use homogeneous (dissolved) chiral catalysts…